JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.
Baird Maintains Outperform on Icon, Raises Price Target to $265
Baird analyst Eric Coldwell maintains Icon (NASDAQ:ICLR) with a Outperform and raises the price target from $260 to $265.